What does royalty bearing sales of developed products mean?

Measures the volume or value of product sales that trigger royalty payments to third-party intellectual property holders. It helps investors assess the company's reliance on licensed technology and the associated variable cost structure.

Ondas, Inc. ONDS Royalty Bearing Sales Of Developed Products

Royalty Bearing Sales Of Developed Products at other companies

BridgeBio PharmaBBIO

$9.5M+4,557%

Elanco Animal Health Inc.ELAN

$9M—

Axsome TherapeuticsAXSM

$4.07M+269%

BalchemBCPC

$493K+7.6%

VicorVICR

$14.97M+39.1%

RepligenRGEN

$44K+25.7%

Other financials

Income statement

See full

Revenue$50.1M+1,080%

Gross profit$24.7M+1,557%

Operating income-$42.7M-314%

Net income$362.8M+2,666%

EPS (diluted)$0.56+473%

Balance sheet

See full

Cash & equivalents$1.0B+3,989%

Total debt$12.5M-64.8%

Total equity$1.1B+4,018%

Total assets$2.4B+2,232%

Cash flow

See full

Operating cash flow-$51.3M-670%

CapEx$1.3M+679%

Free cash flow-$52.6M-671%

Valuation

See full

Market cap$4.82B+3,648%

Profitability

See full

Gross margin44.8%+24.2pp

Operating margin-93.9%-39.2pp

Net margin253.3%+158pp

FCF margin-89.6%-37.2pp

Returns & leverage

See full

Return on equity44.5%+25.0pp

Debt / equity0×-1.4×

Current ratio10.9×+10.1×

Where this comes from

Reported directly by Ondas, Inc. in its filing.

Tagged under the XBRL concept onds:RoyaltyBearingSalesOfDevelopedProducts.

The official record: Ondas, Inc. ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ondas, Inc. 's royalty bearing sales of developed products.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ondas, Inc. 's royalty bearing sales of developed products?: Ondas, Inc. (ONDS) reported royalty bearing sales of developed products of 3% in Q4 2025.
What does royalty bearing sales of developed products mean?: Measures the volume or value of product sales that trigger royalty payments to third-party intellectual property holders. It helps investors assess the company's reliance on licensed technology and the associated variable cost structure.